Skip to main content

Want a detailed portfolio tracker?

Bio-Techne (TECH) P/E (2009 - 2026)

Bio-Techne (TECH) P/E from Sep 30, 2009 to Jul 21, 2026. The TTM Bio-Techne (TECH) P/E is 102.17. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Bio-Techne (TECH)

YearP/EChange
2026102.17-9.83%
2025113.30+57.35%
202472.00+46.09%
202349.29+10.61%
202244.56-53.71%
202196.27+37.78%
202069.87+62.90%
201942.89-24.12%
201856.53-68.24%
2017178.00+355.91%
201639.04+15.75%
201533.73+13.97%
201429.59-3.29%
201330.60+33.74%
201222.88+2.50%
201122.32+1.39%
201022.02-56.26%
200950.33N/A

Comparison Bio-Techne (TECH) P/E with competitors

Bio-Techne (TECH) P/E is 102.17.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.00%
NBYStablecoin Development Corp0.00-100.00%
ENLVEnlivex Ltd0.07-99.93%
FGENFibroGen Inc0.24-99.77%
CHRSCoherus Biosciences Inc0.85-99.17%
FBIOFortress Biotech Inc0.95-99.07%
ORMPOramed Pharmaceuticals Inc1.50-98.53%
AGENAgenus Inc3.01-97.05%
INVAInnoviva Inc3.15-96.91%
VXRTVaxart Inc3.55-96.53%
CRMDCorMedix Inc3.63-96.45%
CVACCureVac N.V.4.45-95.65%
GLPGGalapagos NV4.86-95.24%
SRPTSarepta Therapeutics Inc4.88-95.22%
ABEOAbeona Therapeutics Inc5.39-94.73%
ABUSArbutus Biopharma Corp5.60-94.52%
ZVRAZevra Therapeutics Inc5.89-94.24%
SPROSpero Therapeutics Inc6.23-93.90%
CGENCompugen Ltd6.31-93.82%
RIGLRigel Pharmaceuticals6.87-93.27%
SLXNSilexion Therapeutics Corp7.30-92.86%
OMEROmeros Corporation9.26-90.94%
AUPHAurinia Pharmaceuticals Inc9.58-90.62%
PLXProtalix BioTherapeutics Inc10.89-89.34%
ACADAcadia Pharmaceuticals Inc11.73-88.52%
TBPHTheravance Biopharma Inc12.26-88.00%
ADMAAdma Biologics Inc12.42-87.85%
HRMYHarmony Biosciences Holdings Inc13.82-86.47%
SABSSAB Biotherapeutics Inc14.14-86.16%
NAGENiagen Bioscience Inc14.82-85.50%
INCYIncyte Corp15.82-84.51%
REGNRegeneron Pharmaceuticals Inc15.86-84.48%
PBYIPuma Biotechnology Inc17.32-83.05%
CPRXCatalyst Pharmaceuticals Inc17.44-82.93%
EXELExelixis Inc17.54-82.83%
TGTXTG Therapeutics Inc18.97-81.44%
MDXGMimedx Group Inc20.55-79.88%
XOMAXOMA Royalty Corp22.87-77.61%
ARGXArgen X SE24.30-76.22%
CTMXCytomX Therapeutics Inc24.82-75.71%
XOMAOXOMA Royalty Corp25.34-75.19%
HALOHalozyme Therapeutics Inc25.62-74.92%
XOMAPXOMA Royalty Corp25.67-74.87%
VRTXVertex Pharmaceuticals Inc27.99-72.60%
RPRXRoyalty Pharma plc - Class A28.69-71.92%
SLNOSoleno Therapeutics Inc29.02-71.60%
ASNDAscendis Pharma A/S30.09-70.55%
LGNDLigand Pharmaceuticals Inc - Class B37.91-62.89%
APLSApellis Pharmaceuticals Inc39.02-61.81%
BMRNBiomarin Pharmaceutical Inc42.21-58.68%
KRYSKrystal Biotech Inc45.34-55.62%
ONCBeiGene Ltd69.54-31.93%
PHARPharming Group N.V.75.03-26.56%
VCELVericel Corp109.92+7.59%
ALNYAlnylam Pharmaceuticals Inc117.96+15.46%
GMABGenmab140.29+37.32%
TLXTelix Pharmaceuticals Ltd162.15+58.72%
CORTCorcept Therapeutics Inc212.86+108.35%